Opiate receptors play major roles in analgesic and euphoric effects of
opiate drugs. Recent cloning of cDNAs encoding the rodent and human m
u receptor revealed high homology between the predicted receptors but
also some sequence differences. To determine if these sequence differe
nces produced significant changes in ligand-selectivity profiles, we a
ssessed these profiles in expressing COS and CHO cell lines using the
agonist ligand [I-125]IOXY-AGO (6 beta-[(125)Iodo]-3,14-dihydroxy-17-m
ethyl-4,5 alpha-epoxymorphinan). This Ligand's high specific activity
(2,200 Ci/mmol) and high affinity for mu opioid receptors generated hi
gh signal-to-noise ratio binding. The resulting ligand-selectivity pro
files of the human and rat mu receptors reveal modest differences in a
ffinities for morphine and naloxone in COS cells but not CHO cells. Li
gand-selectivity profiles of the rat and human mu, receptors were othe
rwise similar. Interesting differences between these data and data pre
viously obtained with the peptide agonist [H-3]DAMGO suggest that the
peptide and alkaloid agonists may label different domains of the mu re
ceptor. (C) 1995 Wiley-Liss, Inc.()